Integrating Anxiety Sensitivity, Distress Tolerance, and Discomfort Intolerance: A Hierarchical Model of Affect Sensitivity and Tolerance

2009 ◽  
Vol 40 (3) ◽  
pp. 291-301 ◽  
Author(s):  
Amit Bernstein ◽  
Michael J. Zvolensky ◽  
Anka A. Vujanovic ◽  
Rudolf Moos
2013 ◽  
Vol 27 (1) ◽  
pp. 147-154 ◽  
Author(s):  
Melissa A. Mitchell ◽  
Christina J. Riccardi ◽  
Meghan E. Keough ◽  
Kiara R. Timpano ◽  
Norman B. Schmidt

2021 ◽  
Author(s):  
Andrea Woznica

This study extended research on the specificity of the effects of the carbon dioxide (CO₂) challenge by examining panic reactivity in participants with bulimia nervosa (BN) (n=15) compared to those without bulimia nervosa (n=31). All participants completed self-report measures assessing state and trait anxiety, depression, anxiety sensitivity (AS), distress tolerance (DT), discomfort intolerance (DI), and eating disorder features. They subsequently breathed two vital capacity inhalations; room air and 35% CO₂-enriched air. Reactivity to room air was not different between groups. However, participants with BN displayed greater reactivity to CO₂ compared to the participants with BN. AS, DI, and DT could not be tested as potential mediators in the association between diagnostic group and reactivity because these constructs were not associated with reactivity. Eating disorder features and frequency of binges and purges were also not associated with reactivity. Detailed implications and suggestions for further research are discussed.


2020 ◽  
Vol 27 (6) ◽  
pp. 717-725
Author(s):  
Casey D. Wright ◽  
Cecelia I. Nelson ◽  
Jamey T. Brumbaugh ◽  
Daniel W. McNeil

2010 ◽  
Vol 210 (1) ◽  
pp. 25-34 ◽  
Author(s):  
Kenneth A. Perkins ◽  
Joshua L. Karelitz ◽  
Grace E. Giedgowd ◽  
Cynthia A. Conklin ◽  
Michael A. Sayette

2020 ◽  
Vol 139 ◽  
pp. 110269
Author(s):  
Rachel M. Ranney ◽  
Hanaan Bing-Canar ◽  
Katherine C. Paltell ◽  
Jana K. Tran ◽  
Erin C. Berenz ◽  
...  

2019 ◽  
Vol 22 (1) ◽  
pp. 58-65 ◽  
Author(s):  
Tanya R Schlam ◽  
Timothy B Baker ◽  
Stevens S Smith ◽  
Jessica W Cook ◽  
Megan E Piper

Abstract Introduction This study examined relations of two affective vulnerabilities, high anxiety sensitivity (AS) and low distress tolerance (DT), with tobacco dependence, withdrawal, smoking cessation, and pharmacotherapy response. Methods Smokers interested in quitting (N = 1067; 52.2% female, 28.1% African American) were randomized to 12 weeks of nicotine patch, nicotine patch plus nicotine lozenge, or varenicline. Baseline questionnaires assessed AS, DT, negative affect, anxiety, and dependence. Withdrawal was assessed the first-week post-quit via ecological momentary assessment. Results DT, but not AS, predicted biochemically confirmed point-prevalence abstinence at multiple endpoints: weeks 4, 12, 26, and 52 post-quit (ps < .05); relations remained after controlling for pharmacotherapy treatment, AS, baseline negative affect, anxiety, and anxiety disorder history (ps < .05). Additional exploratory analyses examining week 4 abstinence showed DT predicted abstinence (p = .004) even after controlling for baseline dependence, post-quit withdrawal (craving and negative affect), and treatment. DT moderated treatment effects on abstinence in exploratory analyses (interaction p = .025); those with high DT were especially likely to be abstinent at week 4 with patch plus lozenge versus patch alone. Conclusions DT, but not AS, predicted abstinence over 1 year post-quit (higher DT was associated with higher quit rates), with little overlap with other affective measures. DT also predicted early abstinence independent of dependence and withdrawal symptoms. Results suggest low DT may play a meaningful role in motivation to use tobacco and constitute an additional affective risk factor for tobacco cessation failure beyond negative affect or clinical affective disorders. Implications People in a stop-smoking study who reported a greater ability to tolerate distress were more likely to quit smoking and remain smoke-free 1 year later. Smokers with high DT were more likely to be smoke-free 4 weeks after their target quit day if they received nicotine patch plus nicotine lozenge rather than nicotine patch alone. Trial Registration NCT01553084.


Sign in / Sign up

Export Citation Format

Share Document